STAT3 and cancer: Finally, we studied STAT3 signalling in c-Abl-deficient PCs as c-Abl and its chimeric oncoproteins had been shown to regulate the activation of STAT3 in cancer cells26, 27, 28 and separately, STAT3 has been shown to regulate PCs survival in several recent studies29, 30, 31.